2026 brings seismic shifts to pharmacy benefits – sweeping legislation, transparency demands, and evolving PBM models are creating both challenges and opportunities. Your clients need clarity and strategies to stay ahead. 

This Q1 Market Report arms you with the insights to: 

• Decode federal and state legislative changes driving transparency and accountability. 
• Compare traditional PBMs to disruptor models like cost-plus and transparent pricing. 
• Leverage independent clinical oversight to eliminate wasteful spending and manage specialty drug costs.

Why it matters now: 

• Regulatory pressure is mounting: landmark reforms demand compliance and transparency. 
• Specialty drug costs are soaring: 55% of drug spend comes from just 2% of members. 
• Clients expect leadership: Be the advisor who delivers clarity and solutions. 

Don’t wait – download the report and position yourself as the expert your clients need in this rapidly evolving landscape